Results 161 to 170 of about 3,610 (188)
Some of the next articles are maybe not open access.

Does ▼eflornithine help women face hirsutism?

Drug and Therapeutics Bulletin, 2007
Many women develop male-pattern facial hair (facial hirsutism), which can be distressing and difficult to treat. ▼Eflornithine (Vaniqa – Shire) is a topical cream available only on prescription for treating women with facial hirsutism. Promotional material claims that the treatment “slows facial hair growth – grows her confidence”.
openaire   +2 more sources

Vaniqa--eflornithine 13.9% cream.

Skin therapy letter, 2001
Eflornithine HCl 13.9% cream is the first topical prescription treatment to be approved by the US FDA for the reduction of unwanted facial hair in women. It irreversibly inhibits ornithine decarboxylase (ODC), an enzyme that catalyzes the rate-limiting step for follicular polyamine synthesis, which is necessary for hair growth.
J, Shapiro, H, Lui
openaire   +1 more source

Eflornithine

American Journal of Health-System Pharmacy, 2001
openaire   +3 more sources

Eflornithine (Iwilfin) for High-Risk Neuroblastoma

The Medical Letter on Drugs and Therapeutics
Eflornithine (Iwilfin – US WorldMeds), an oral ornithine decarboxylase inhibitor, has been approved by the FDA to reduce the risk of relapse in children and with high-risk neuroblastoma who had at least a partial response to prior multiagent, multimodality therapy, including anti-GD2 immunotherapy.
openaire   +2 more sources

Eflornithine

2020
Ronak G. Gandhi, Ramy H. Elshaboury
openaire   +2 more sources

Eflornithine

Reactions Weekly, 1991
openaire   +1 more source

Eflornithine-Finasteride

Acta Clinica Belgica, 1994
openaire   +1 more source

Eflornithine

Reactions Weekly, 2015
openaire   +1 more source

The eflornithine story

Journal of the American Academy of Dermatology, 2001
openaire   +2 more sources

Home - About - Disclaimer - Privacy